FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to cardiosurgery. Patient is subjected to preliminary multiple laser myocardium revascularisation with further introduction into myocardium of autologic cell culture. As cell culture used is suspension of cardiomyoblasts in isotonic physiological solution, containing 2×108 cells, in presence of heparin, multiplied during 35-40 days "in vitro" from mesenchymal autologic stem cells of bone marrow, extracted from the patient said time before carrying out treatment. Suspension is introduced by means of multiple injections around zone of ischemic but viable myocardium, avoiding laser channels, total amount of introduced suspension constituting 8-10 ml. Method ensures high efficiency of treatment of heart diseases of ischemic genesis.
EFFECT: ensuring high efficiency of treatment of heart diseases of ischemic genesis.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SURGICAL MANAGEMENT OF ISCHEMIC HEART DISEASE | 2017 |
|
RU2685375C1 |
| METHOD FOR TREATING ISCHEMIC TISSUE ALTERATIONS | 2005 |
|
RU2295964C1 |
| METHOD FOR TREATING THE DISEASES OF DIFFERENT ETIOLOGY AND TRAUMAS OF DIFFERENT ORGANS | 2005 |
|
RU2301667C1 |
| BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE | 2004 |
|
RU2268061C1 |
| BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC CARDIAC FAILURE (VARIANTS) | 2005 |
|
RU2299073C1 |
| METHOD OF TREATING CARDIOVASCULAR DISEASE | 2023 |
|
RU2822010C1 |
| BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING DILATION CARDIOMYOPATHY | 2004 |
|
RU2268062C1 |
| METHOD FOR TREATING MYOCARDIAL INFARCTION | 2005 |
|
RU2294206C2 |
| BIOTRANSPLANT CONTAINING NUCLEUS-CONTAINING BONE MARROW CELLS INCLUDING PREDIFFERENTIATED IN ENDOTHELIAL AND CARDIOMYOCYTIC DIRECTION, METHOD FOR PRODUCING IT AND METHOD FOR TREATING CARDIAC INSUFFICIENCY CASES | 2006 |
|
RU2314816C2 |
| METHOD OF CHRONIC CARDIAC INSUFFICIENCY MEDICAL TREATMENT | 2006 |
|
RU2325934C1 |
